Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1K Sell
14
-300
-96% -$14.6K ﹤0.01% 146
2022
Q2
$16K Sell
314
-68
-18% -$3.46K 0.01% 132
2022
Q1
$20K Buy
+382
New +$19.8K 0.01% 148

Other funds holding PFE

Siena Capital's PFE Position: Q3 2022 in Review

Siena Capital reduced its Pfizer (PFE) stake by 96% in Q3 2022, selling an estimated $14.6K and leaving 14 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #146.

Siena Capital first reported a position in PFE in Q1 2022 and has held it in 3 quarters since. The position peaked at $20K in Q1 2022. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Siena Capital held 14 shares of Pfizer worth $1K as of Q3 2022.
  • Siena Capital sold 300 Pfizer shares in Q3 2022, an estimated $14.6K.
  • Pfizer made up ﹤0.01% of Siena Capital's portfolio in Q3 2022, its #146 holding.
  • Siena Capital first reported a position in Pfizer in Q1 2022 and has held it in 3 quarters since.
  • Siena Capital's Pfizer position peaked at $20K in Q1 2022.
  • 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.